Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

25246454865 f98809ba7b k

News and Trends 23 Aug 2016

€350M CRISPR Joint Venture now has a Name and an Office

Bayer and CRISPR Therapeutics have invested $373M in a joint venture, Casebia, as the latest effort to bring the revolutionary gene editing technology to the medical market. This brainchild represents a huge leap of faith, since no preliminary results have been revealed. The Boston launch may accelerate its progress through clinical trials and produce the first […]

August 23, 2016 - 3 minutesmins - By Evelyn Warner

Accelerators And Biotech Startups cover

In Depth 23 Aug 2016

5 Expert Tips to Success When Building a Biotech Startup

Succeeding as an entrepreneur is tough, you will have to deal with failure and learn from it along the way. Many new biotech startups face similar problems during their early steps, here are some expert tips on how to avoid them. Last week, I had the opportunity to meet Mark Hammond and Dominic Falcao, who […]

August 23, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

sanofi novo nordisk diabetes insulin glp 1 agonist combination

News and Trends 22 Aug 2016

Sanofi loses lead on new Diabetes drug, because of… an user-unfriendly Pen

Sanofi and Novo Nordisk have been in a tight race to put their new insulin GLP-1 combination drugs for Type 2 Diabetes on the market. Sanofi now suffers a short (but critical) setback, as the FDA is not impressed with its drug delivery system. Sanofi and Novo Nordisk have both strong positions in the diabetes […]

August 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

2154054251 b22ce00739 o

News and Trends 22 Aug 2016

This new vaccine could tackle both Zika and Dengue at once

These potentially fatal diseases have reached pandemic proportions and are starting to threaten the Western world. Excivion (UK) and Xenetic (US) have announced a partnership to develop a combined vaccine for Dengue and Zika Viruses using new vaccine delivery technology. Following on Sanofi’s initiatives to combat the spread of Zika and Dengue viruses, a transatlantic partnership between […]

August 22, 2016 - 2 minutesmins - By Evelyn Warner

sanofi biotech acquisition medivation msd

News and Trends 22 Aug 2016

UPDATE: Sanofi defeated in the Race to acquire Medivation

Even more Big Pharma join the fight to acquire the extremely desirable Medivation, a Biotech developing cancer treatments. Now MSD is joining the bandwagon. Things don’t look so good for Sanofi, which already got rebuffed twice. UPDATE (article originally published on 18/8/2016): Pfizer has struck a deal to acquire Medivation for $14Bn (€12.4Bn), according to the Financial Times. This was […]

August 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

microbiology 163470 960 720

News and Trends 22 Aug 2016

Now we can watch DNA Repair itself!

After 2015’s Nobel Prize in chemistry was awarded for advancements in our understanding of DNA repair, a recent Nature report characterises the mechanism in molecular detail. The implications for cancer research are vast. Researchers in Paris, France, and Bristol, England, have leveraged recent advances in microscopy and fluorescent imaging to characterise the entire process of DNA […]

August 22, 2016 - 2 minutesmins - By Evelyn Warner

ADVERTISEMENT

3387697 orig

News and Trends 20 Aug 2016

France is loving this Iranian Bioartist’s Microbe-Inspired Installations

Bioartist Golnaz Behrouznia creates gorgeous multimedia installations inspired by microscopic life. Keep an eye out for her work at festivals in Paris and Toulouse this September. Golnaz Behrouznia has always been passionate about natural science, particularly the world seen through a microscope. Through a combination of plastic sculpture, drawing, and installation video, she brings it […]

August 20, 2016 - 2 minutesmins - By Evelyn Warner

inotrem nancy france inflammation startup

News and Trends 19 Aug 2016

Inotrem on its way to Control Acute Inflammation

We leave the North of Spain, meander through the Pyrenees and prendons un verre du vin français before arriving in Nancy. Here, we can visit the city’s UNESCO World Heritage Site and have a good quiche Lorraine. Then, it’s time to head to Inotrem, our Biotech of the Week. City: Nancy, France Founded: 2013 Employees: 12 Financial Data: €18M […]

August 19, 2016 - 1 minutemin - By Denise Neves Gameiro

5161819684 9cfa881f1f o

News and Trends 18 Aug 2016

Invidior approaches FDA Approval of Opioid Addiction Treatment

Invidior has revamped buprenorphine with a sustained release formulation known as RBP-6000 that shows promising results in Phase III clinical trials for the treatment of opioid addiction. The latest addiction treatment from Invidior, RBP-6000, has made considerable progress through Phase III clinical trials. At the core of RBP-6000 is the old drug, buprenorphine, but Invidior has […]

August 18, 2016 - 3 minutesmins - By Evelyn Warner

nanoparticle eye drops oculis series a

News and Trends 18 Aug 2016

This Icelandic Start-Up just raised Money to turn injections into Eye-Drops

Oculis just closed its Series A fundraising with the help of Icelandic investors. The money will help get its first eye-drops in the market, to treat diabetic macular edema (DME) without injections or implants. Based in Reykjavik, Oculis was founded in 2003 to develop a new drug delivery platform. This technology consists of solubilizing nanoparticles (SNP), which […]

August 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

synthetic biology bioelectronics igem living lightbulb

News and Trends 17 Aug 2016

Illuminating Synthetic Biology: Undergraduate team develops a bioelectric lightbulb

A group of undergraduate researchers at Newcastle University has created a lightbulb from genetically engineered E. coli. In the pipeline are also a hybridised batteries, a capacitor, and a resistor, and the forthcoming circuit will serve as the team’s entry into 2016’s iGEM competition. We’ve heard of fungi furniture, but synthetic biology is extending tendrils into another area of interior design: […]

August 17, 2016 - 2 minutesmins - By Evelyn Warner

nsclc cancer vaccine immunotherapy opdivo combo

News and Trends 17 Aug 2016

Bavarian Nordic gets hold of Opdivo for new Combination Phase II trial

Just after a major clinical failure, BMS is now shipping Opdivo to Bavarian Nordic for a Phase II trial. Sponsored by Bavarian Nordic, the planned trial will evaluate the combination of a cancer vaccine and the anti-PD-L1 checkpoint inhibitor. Checkpoint blocking has generated a lot of excitement in cancer treatments as part of the immuno-oncology […]

August 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT